Maybe this thread should be called "new challenge for Implant Direct reps" since it looks like they have a whole bunch of serious recalls that could endanger their patients, and cause bacteria to get inside their packaging. This is is some turn of events. This recall is official, and not fabricated by Nobel, since it was mandated by the Canadian Government. All the Nobel reps in both countries have been briefed on how to react to IP misinformation campaign if it ever comes up in discussion with the doctors. So far nothing. It is ironic that Niznick's attempt to discrediting Nobel's reputation has only creates an even lower level of credibility for Niznick's company.
YES, a leaking implant vial could cause bacteria to get inside and endanger patients.
NO, Implant Direct's implant vials with micro-cracks, removed from our inventory in August 2007 did not compromise the integrity of the seal of its sterile implant vials. This is well documented by the published leak tests done in 2007 and repeated in 2009 on the same vials. The results of these tests are posted on implant Direct's website at:
http://www.implantdirect.com/newsletter_0/newsletter_18/pdf/appendix5.pdf
YES, there is strong evidence now in the hands of Health Canada and the FDA that Nobel Biocare's Implant Vials, currently being sold as sterile, in fact fail the industry standard dye leak test conducted by an independent testing laboratory approved by the FDA.
http://www.implantdirect.com/newsletter_0/newsletter_18/pdf/appendix2_sm.pdf
Nobel Biocare, in an act of shear desperation, and without adequate consideration for the unintended consequences that would result, sought to exploit the cosmetic micro-crack incident two years after the fact as explained below in the Narrative filed with the FDA:
http://www.implantdirect.com/newsletter_0/newsletter_18/pdf/ReportNarrative_091809.pdf
Here is an excerpt of that Narrative:
"In June 2009, Implant Direct Canada demoted its Director of Operations, Ms.
Adele Fussi, to a sales position. She resigned and, while negotiating for a high
paying position with Nobel Biocare, reported Implant Direct to Health Canada
regarding a packaging issue that Implant Direct had experienced two years
earlier. This resulted in an inquiry by Health Canada that has since been
resolved. The packaging issue related to an August 2007 removal from inventory
of a small number of implants with a cosmetic, micro-crack in the cap. Implant
Direct, using standard leak tests conducted in August 2007 and again in July
2009 confirmed that these micro-cracks did not result in a loss of the sterile seal.
In August 2007, the white caps were replaced with clear caps of a different
material eliminating the potential for micro-cracks following sterilization. Only
seven (7) implants with micro-cracks, shipped prior to August 2007 to Canadian
dentists were retrieved and exchanged for newer product. When Ms. Fussi and
her sales managers at Nobel Biocare started to contact Implant Direct’s
customers with misinformation about Implant Direct’s packaging and Health
Canada’s response, Implant Direct initiated litigation that is now pending in
Canada."
Implant Direct satisfied the Canada Health authorities concerns by demonstrating that it had done dye leak tests on 125 implant vials with micro-cracks, which represented 25% of all such vials, and proved that these vials maintained the integrity of their sterile seal. CASE Closed!
Implant Direct initiated a voluntary inventory recovery in Canada, finding only 7 implant vials with Micro-cracks, and exchanged those products without incident. We have proposed to the FDA to do the same in the US but have not heard yet whether they think this is necessary. Recalls are not uncommon in the medical device industry as can be seen by the fact that Nobel is also listed as having a recall on the same Canada Health link provided on Cafepharma.
A search of the web under Nobel Biocare Recall reveals many incidences of Recalls by Nobel including 4 in a two month period as shown by this link.
http://mdiconsultants.com/section_ni/fda_recalls/recallarchive7.htm
While any incidence, voluntary or involuntary, requiring exchange or recall of products is unfortunate, Implant Direct's regulatory record is enviable, having only this one incident that did not in any way compromise sterility or clinical success. Nobel's attempt to exploit this by hiring a former employee of Implant Direct at $130,000 for the year, who was herself in charge of removing the products from Implant Direct's inventory at the request of our QA personnel, set in motion a series of events, the outcome of which has yet to be fully appreciated. Needless to say, if the FDA and Health Canada take seriously, Implant Direct's sale of a few implants with a cosmetic micro-crack that did not effect sterility, they are not likely to ignore the sale by Nobel Biocare, of hundreds of thousands of implants and other surgical components that potentially fail a simple dye leak test to assure the maintenance of sterility?
For you Nobel reps trying to console yourself by pointing at the Health Canada website listing a number of Implant Direct's implants that could potentially have been sold with micro-cracks (only 7 recovered and exchanged), here is something else to worry about. A study presented at the EAO meeting in Monico last week, comparing the results of Nobel Replace implants and Implant Direct RePlant implants placed side by side in maxillary jaws all using Nobel Guide and immediate loading, documented 13% of the Nobel Replace implants failed compared to only 1% of the RePlant Implants.
http://www.implantdirect.com/pdf/EAO_ImplGuidSurg_Final.pdf